Literature DB >> 10941095

Microchips as Controlled Drug-Delivery Devices.

J T Santini1, A C Richards, R Scheidt, M J Cima, R Langer.   

Abstract

Controlled-release systems are common in a number of product areas, including foods, cosmetics, pesticides, and paper. Microencapsulated systems, for example, are used for the release of flavors and vitamins in foods, fragrances in perfumes, and inks in carbonless copy paper. Controlled-release systems for drug delivery first appeared in the 1960s and 1970s. In the past three decades, the number and variety of controlled release systems for drug-delivery applications has increased dramatically. Many of these use polymers having particular physical or chemical characteristics such as biodegradability, biocompatibility, or responsiveness to pH or temperature changes. However, recent advances in the field of microfabrication have created the possibility of a new class of controlled-release systems for drug delivery, namely, that of small, programmable devices. Their small size, potential for integration with microelectronics, and ability to store and release chemicals on demand could make controlled-release microchips useful in a number of areas, including medical diagnostics, analytical chemistry, chemical detection, industrial process monitoring and control, combinatorial chemistry, microbiology, and fragrance delivery. More importantly, drug-delivery microchips resulting from this convergence of controlled release and microfabrication technologies may provide new treatment options to clinicians in their fight against disease.

Entities:  

Year:  2000        PMID: 10941095

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  32 in total

1.  Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration.

Authors:  Alessandro Grattoni; Haifa Shen; Daniel Fine; Arturas Ziemys; Jaskaran S Gill; Lee Hudson; Sharath Hosali; Randy Goodall; Xuewu Liu; Mauro Ferrari
Journal:  Pharm Res       Date:  2010-07-01       Impact factor: 4.200

2.  An implantable MEMS micropump system for drug delivery in small animals.

Authors:  Heidi Gensler; Roya Sheybani; Po-Ying Li; Ronalee Lo Mann; Ellis Meng
Journal:  Biomed Microdevices       Date:  2012-06       Impact factor: 2.838

3.  Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.

Authors:  Byron C Masi; Betty M Tyler; Hansen Bow; Robert T Wicks; Yuan Xue; Henry Brem; Robert Langer; Michael J Cima
Journal:  Biomaterials       Date:  2012-05-14       Impact factor: 12.479

Review 4.  Application of micro- and nano-electromechanical devices to drug delivery.

Authors:  Mark Staples; Karen Daniel; Michael J Cima; Robert Langer
Journal:  Pharm Res       Date:  2006-05-05       Impact factor: 4.200

5.  Electroactive controlled release thin films.

Authors:  Kris C Wood; Nicole S Zacharia; Daniel J Schmidt; Stefani N Wrightman; Brian J Andaya; Paula T Hammond
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

6.  A microfluidic chip for controlled release of drugs from microcapsules.

Authors:  Wen-Chuan Cheng; Yuan He; An-Yi Chang; Long Que
Journal:  Biomicrofluidics       Date:  2013-11-06       Impact factor: 2.800

7.  Designing hydrogels for controlled drug delivery.

Authors:  Jianyu Li; David J Mooney
Journal:  Nat Rev Mater       Date:  2016-10-18       Impact factor: 66.308

Review 8.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

Review 9.  Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems.

Authors:  Mary Caldorera-Moore; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2009-09-14       Impact factor: 15.470

Review 10.  Spatiotemporal control over growth factor signaling for therapeutic neovascularization.

Authors:  Lan Cao; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.